Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better reassurances to customers

Former CEO Anne Wojcicki has prevailed in the bankruptcy auction of 23andMe, its consumer and biopharma research businesses, and its trove of genetic data.  | Her $305 million offer topped the previous frontrunner,

Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the DNA-testing company after a nonprofit she controls, TTAM Research Institute, submitted a winning bid of $305 million for 23andMe’s assets, according to The Wall Street Journal.

The DNA data of more than 15 million customers of DNA testing firm 23andMe is set to be returned to the control of 23andMe co-founder and former CEO Anne Wojcicki, after the non-profit she leads outbid previously announced buyer, biotech Regeneron, by $70 million.